*Introduction MaaT Pharma, a clinical-stage biotechnology company committed to treating cancer and graft-versus-host disease (GvHD), a serious complication of allogeneic stem cell transplantation. The companys Microbiome Ecosystem Therapies are produced through a standardized cGMP manufacturing and quality control process to safely deliver the full diversity of the microbiome (eg: the entire microbiome ecosystem) in…
MP
MaaT Pharma
Company · France
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
3
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track MaaT in PolicySpeak: request access →
Work at MaaT Pharma? so we know who speaks for it.
Their record over time
MaaT Pharma filed 3 positions between 8 Sept 2022 and 8 Nov 2023, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.
2022 · 2 filed2023 · 1 filed
What they argued
Introduction We acknowledge the European Commission’s proposal on standards of quality and safety for Substances of Human Origin (SoHO) for human application and welcomes the opportunity to participate to this consultation.
We acknowledge the European Commission’s proposal on standards of quality and safety for Substances of Human Origin (SoHO) for human application and welcomes the opportunity to participate to this consultation. This will increase EU harmonization on protection of the rights and safety of SoHO donors and recipients and create a regulatory status and common rules for SoHOs currently not regulated neither as medicinal…
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put MaaT Pharma next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 26.
Is this your organization?
Everything on this page comes from MaaT Pharma’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.